Senescence of activated stellate cells: Not just early retirement

Hepatology

Volumn 49, Issue 3, 2009, Pages 1045-1047

  Schrader, Jörg ^a   Fallowfield, Jonathan ^a   Iredale, John P ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA; PROTEIN P16; PROTEIN P21; PROTEIN P53;

CELL AGING; CELL CYCLE ARREST; CELL PROLIFERATION; DOWN REGULATION; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GENE SILENCING; IMMUNOSURVEILLANCE; ITO CELL; LIVER FIBROSIS; LIVER INJURY; MYOFIBROBLAST; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REMISSION; SCAR; SHORT SURVEY; STELLATE CELL; UPREGULATION;

EID: 67449162071     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22832     Document Type: Short Survey

References (14)

1. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008;134:1655-1669.
2. Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, et al. Mechanisms of spontaneous resolution of rat liver fibrosis: Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 1998;102:538-549.
3. Radaeva S, Sun R, Jaruga B, Nguyen VT, Tian Z, Gao B. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology 2006;130:435-452.
4. Schnabl B, Purbeck CA, Choi YH, Hagedorn CH, Brenner DA. Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype. HEPATOLOGY 2003;37:653-664.
5. Novo E, Marra F, Zamara E, Valfrè di Bonzo L, Monitillo L, Cannito S, et al. Overexpression of Bcl-2 by activated human hepatic stellate cells: Resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans. Gut 2006;55:1174-1182.
6. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965;37:614-636.
7. Campisi J, d'Adda di Fagagna F. Cellular senescence: When bad things happen to good cells. Nat Rev Mol Cell Biol 2007;8:729-740.
8. Collado M, Blasco MA, Serrano M. Cellular senescence in cancer and aging. Cell 2007;130:223-233.
9. Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, Miething C, et al. Senescence of activated stellate cells limits liver fibrosis. Cell 2008;134:657-667.
10. Wiemann SU, Satyanarayana A, Tsahuridu M, Tillmann HL, Zender L, Klempnauer J, et al. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis. FASEB J 2002;16:935-942.
11. Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007;445:656-660.
12. Rudolph KL, Chang S, Millard M, Schreiber-Agus N, DePinho RA. Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery. Science 2000;287:1253-1258.
13. Sasaki M, Ikeda H, Yamaguchi J, Nakada S, Nakanuma Y. Telomere shortening in the damaged small bile ducts in primary biliary cirrhosis reflects ongoing cellular senescence. HEPATOLOGY 2008;48:186-195.
14. Hoare M, Gelson W, Das A, Fletcher JM, Davies S, Curran MD, et al. Immune senescence, independent of age, informs the clinical outcome of chronic hepatitis C virus (HCV) infection [Abstract]. HEPATOLOGY 2008; 48(Suppl):780A-781A.